Advertisement
Publications
Subscribe
Issues
Current Issue
Archive
Digital Supplements
Diseases & Conditions
Diabetic Retinopathy
Endophthalmitis
Epiretinal Membrane
Geographic Atrophy
View All
Topics
Case Studies
Practice Management
Surgery Tips and Strategies
Gene therapy
View All
Subspecialties
Pediatric Retina
Uveitis
Medical Retina
Ocular Oncology
View All
Events
Corneal Physician Symposium
Glaucoma Physician Symposium
Resources
About
Article Reprints
Societies and Associations
Submission Guidelines
Subscribe
Publication to search:
All
Ophthalmology
Optometry
Optometric Management
Ophthalmology Management
Contact Lens Spectrum
Corneal Physician
Eyecare Business
Glaucoma Physician
New Retinal Physician
Ophthalmic Professional
Presbyopia Physician
Retinal Physician
PentaVision
Publications
Ophthalmology Management
Contact Lens Spectrum
Corneal Physician
Eyecare Business
Glaucoma Physician
New Retinal Physician
Ophthalmic Professional
Optometric Management
Presbyopia Physician
Retinal Physician
New Retinal Physician
Issues
Current
Archive
Digital Supplements
Diseases & Conditions
Diabetic Retinopathy
Endophthalmitis
Epiretinal Membrane
Geographic Atrophy
View All
Topics
Case Studies
Practice Management
Surgery Tips and Strategies
Gene therapy
View All
Subspecialties
Pediatric Retina
Uveitis
Medical Retina
Ocular Oncology
Events
Corneal Physician Symposium
Glaucoma Physician Symposium
Resources
About
Article Reprints
Societies and Associations
Submission Guidelines
Ophthalmology Management
Contact Lens Spectrum
Corneal Physician
Eyecare Business
Glaucoma Physician
New Retinal Physician
Ophthalmic Professional
Optometric Management
Presbyopia Physician
Retinal Physician
View Cover
New Retinal Physician
Volume
NRP News: Dosing Proceeds in GA Study 2024
Previous
All Issues
Next
News
Dosing Proceeds in GA Study
OCU410 is a 1-time gene therapy being investigated as a treatment for geographic atrophy.
Previous
Next
Advertisement
Recommendations
Advertisement
Advertisement
